[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100451068":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":23,"responsibleParty":42,"collaborators":7,"id":44,"slug":7,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":7,"eligibilityCriteria":48,"healthyVolunteers":45,"sex":49,"minAge":7,"maxAge":7,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":7,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Ludwig-Maximilians - University of Munich","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"PROCEDURE","Cystectomy","Removal of the urinary bladder",[14],{"name":15,"affiliation":5,"role":16},"Gerald Schulz, PD Dr.","PRINCIPAL_INVESTIGATOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"Benedikt Ebner, Dr.","CONTACT","004917655197898","Benedikt.Ebner@med.uni-muenchen.de",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Urology Department - LMU Klinikum","RECRUITING","Munich","Outside U.S.\u002FCanada","81377","Germany",{"type":32,"coordinates":33},"Point",[34,35],11.57549,48.13743,{"lat":35,"lon":34},[38],{"name":39,"role":20,"phone":40,"phoneExt":7,"email":41},"Benedikt Ebner","017655197898","Benedikt.Ebner@gmx.at",{"type":16,"investigatorFullName":39,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Resident in Urology","100451068",false,"NCT05153694","Infectious Complications After Cystectomy: A Prospective Observational Study","Inclusion Criteria:\n\n* Disease which requires removal of the urinary bladder\n\nExclusion Criteria:\n\n* Patient does not want to participate","ALL",{"count":51,"type":52},200,"ESTIMATED","OBSERVATIONAL","Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.",[56,57,58,59,60,61,62,63],"Bladder Cancer","Infections","Infection, Bacterial","Infection, Hospital","Infection Wound","Urinary Tract Infections","Urinary Bladder Diseases","Urinary Tract Disease","2024-09-13",{"date":66,"type":67},"2024-09-19","ACTUAL",{"date":69,"type":67},"2021-12-01",{"date":71,"type":52},"2025-12-31",{"name":5,"class":6},1]